Drug Trial Radar · NCT05972044
A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)
Last checked: Nov 20, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
516
Actual
Start
Jul 6, 2023
Primary completion
Feb 7, 2025
Study completion Mar 14, 2025
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 2, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with ADHD.
Conditions
- ADHD
Interventions
Solriamfetol 150 mgDrug
Solriamfetol tablets, taken once daily
Solriamfetol 300 mgDrug
Solriamfetol tablets, taken once daily
PlaceboDrug
Placebo tablets, taken once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to Week 6 in the AISRS total scoreTime frame: 6 weeks
Locations
42 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Encino, California
Clinical Research Site
Garden Grove, California
Clinical Research Site
Newport Beach, California
Clinical Research Site
Riverside, California
Clinical Research Site
Santa Ana, California
Clinical Research Site
Sherman Oaks, California
Clinical Research Site
Torrance, California
Clinical Research Site
Walnut Creek, California
Clinical Research Site
Colorado Springs, Colorado
Clinical Research Site
Clermont, Florida
Clinical Research Site
Doral, Florida
Clinical Research Site
Gainesville, Florida
Clinical Research Site
Jacksonville, Florida
Clinical Research Site
Lauderhill, Florida
Clinical Research Site
Miami Lakes, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Marietta, Georgia
Clinical Research Site
Overland Park, Kansas
Clinical Research Site
Boston, Massachusetts
Clinical Research Site
Saint Charles, Missouri
Clinical Research Site
Lincoln, Nebraska
Clinical Research Site
Las Vegas, Nevada
Clinical Research Site
Las Vegas, Nevada
Clinical Research Site
Berlin, New Jersey
Clinical Research Site
Cherry Hill, New Jersey
Clinical Research Site
Princeton, New Jersey
Clinical Research Site
Mount Kisco, New York
Clinical Research Site
New York, New York
Clinical Research Site
Raleigh, North Carolina
Clinical Research Site
Cincinnati, Ohio
Clinical Research Site
Kettering, Ohio
Clinical Research Site
Oklahoma City, Oklahoma
Clinical Research Site
Media, Pennsylvania
Clinical Research Site
North Charleston, South Carolina
Clinical Research Site
Memphis, Tennessee
Clinical Research Site
Austin, Texas
Clinical Research Site
Bellaire, Texas
Clinical Research Site
Dallas, Texas
Clinical Research Site
Dallas, Texas
Clinical Research Site
San Antonio, Texas
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.